Join the Local Anesthesia group to help and get support from people like you.
Local Anesthesia News
Burnout on the Rise Among Anesthesiologists Since Pandemic
TUESDAY, Nov. 14, 2023 – Burnout has increased among anesthesiologists since the start of the COVID-19 pandemic in 2020, according to a study published in the November issue of Anesthesiology. ...
St. Renatus, LLC Announces FDA Approval of Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray for Use in Dentistry
FORT COLLINS, Colo., July 12, 2016 /PRNewswire/ – St. Renatus, LLC, a privately held company based in Fort Collins, Colorado, is pleased to announce it received U.S. Food and Drug Administration...
FDA Medwatch Alert: Sensorcaine-MPF (bupivacaine HCl) by Fresenius Kabi: Recall - Presence of Particulate Matter
ISSUE: Fresenius Kabi USA announced today it is voluntarily recalling a single lot (Lot Number 6111504; Product Code 470237) of Sensorcaine®-MPF (bupivacaine HCl) Injection, USP, 0.75%, 7.5 mg/mL, 30 ...
FDA Medwatch Alert: Bupivacaine HCl Injection by Hospira: Recall - Iron Oxide Particulate In Glass Vials
ISSUE: Hospira issued a voluntary recall of one lot of Preservative-Free Bupivacaine HCl Injection, USP, 0.5% (5 mg/mL), 30 mL Single-dose (NDC: 0409-1162-02, Lot 38-515-DK, Expiry 1FEB2016) due to...
FDA Medwatch Alert: Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter
ISSUE: Hospira announced it will initiate a voluntary recall of one lot of 1% Lidocaine HCI for Injection, USP, 10 mg per mL, 30 mL Single-dose, Preservative-Free to the user level due to a confirmed...
FDA Medwatch Alert: Marcaine (Bupivacaine HCI Injection, USP), 0.5 percent, 30 ML, Single-Dose, Preservative-Free Vial: Recall - Visible Particulates
[Posted 06/18/2014] ISSUE: Hospira announced a voluntary nationwide recall to the user level for one lot of 0.5% Marcaine (Bupivacaine HCl Injection, USP), 30 mL, Single-dose Vial – Preservative F...
FDA Medwatch Alert: Compounded topical anesthetic creams
[Posted 12/06/2006] FDA notified healthcare professionals and consumers about the serious public health risks related to compounded topical anesthetic creams. FDA issued warning letters to five firms...
Ask a question
To post your own question to this support group, sign in or create an account.